Adsorptive Granulocyte and Monocyte Apheresis Is Effective in Ulcerative Colitis Patients Both with and without Concomitant Prednisolone

Background: The number of ulcerative colitis (UC) patients is increasing in Japan and other countries. Selective depletion of myeloid lineage leucocytes by adsorptive granulocyte and monocyte apheresis (GMA) with an Adacolumn (JIMRO, Takasaki, Japan) was introduced as a nonpharmacologic treatment st...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Inflammatory intestinal diseases 2020-02, Vol.5 (1), p.36-41
Hauptverfasser: Matsuda, Keiji, Ohno, Kohei, Okada, Yuka, Yagi, Takahiro, Tsukamoto, Mitsuo, Fukushima, Yoshihisa, Horiuchi, Atsushi, Shimada, Ryu, Ozawa, Tsuyoshi, Hayama, Tamuro, Tsuchiya, Takeshi, Tamura, Junko, Iinuma, Hisae, Nozawa, Keijiro, Aoyagi, Hitoshi, Isono, Akari, Abe, Koichiro, Kodashima, Shinya, Yamamoto, Takatsugu, Kawasaki, Yoshitaka, Tamura, Yoshifuru, Sasajima, Yuko, Kondo, Fukuo, Hashiguchi, Yojiro
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 41
container_issue 1
container_start_page 36
container_title Inflammatory intestinal diseases
container_volume 5
creator Matsuda, Keiji
Ohno, Kohei
Okada, Yuka
Yagi, Takahiro
Tsukamoto, Mitsuo
Fukushima, Yoshihisa
Horiuchi, Atsushi
Shimada, Ryu
Ozawa, Tsuyoshi
Hayama, Tamuro
Tsuchiya, Takeshi
Tamura, Junko
Iinuma, Hisae
Nozawa, Keijiro
Aoyagi, Hitoshi
Isono, Akari
Abe, Koichiro
Kodashima, Shinya
Yamamoto, Takatsugu
Kawasaki, Yoshitaka
Tamura, Yoshifuru
Sasajima, Yuko
Kondo, Fukuo
Hashiguchi, Yojiro
description Background: The number of ulcerative colitis (UC) patients is increasing in Japan and other countries. Selective depletion of myeloid lineage leucocytes by adsorptive granulocyte and monocyte apheresis (GMA) with an Adacolumn (JIMRO, Takasaki, Japan) was introduced as a nonpharmacologic treatment strategy in UC patients in 2000. GMA has been reported to be effective in clinical trials; however, the effect of concomitant prednisolone (PSL) on GMA needs to be clarified. Methods: Thirty-nine patients with active UC were treated with GMA at our institute between June 2009 and September 2018. All patients received GMA therapy once or twice a week with the Adacolumn. Conventional medication was to be continued during the whole GMA treatment course. The clinical response was retrospectively evaluated. Results: According to the partial Mayo score, remission was 33.3%, significant efficacy 25.6%, effective 25.6%, and no response 15.4%. The average partial Mayo score was 6.2 ± 1.4 at entry and significantly declined to 1.8 ± 1.8 after GMA sessions (p < 0.0001). The average number of bowel movements was 9.5 ± 5.6 at entry and significantly declined to 3.0 ± 2.8 after GMA sessions (p < 0.0001). In a comparison between the group treated with concomitant PSL and the group without PSL, the change in partial Mayo score or the number of bowel movements from entry to after GMA sessions was not significantly different. Among 24 patients treated by GMA with concomitant PSL, 75% (18/24) became steroid free. Conclusions: The effect of GMA with concomitant PSL and that of GMA without PSL were not different, and GMA was effective irrespective of PSL administration. The present study showed that GMA had efficacy and led many UC patients treated by PSL to be steroid free with no safety concern in the real world, although there is the possibility of recruitment bias due to the retrospective nature of the study.
doi_str_mv 10.1159/000505484
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1159_000505484</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2385279428</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4064-c3ce3ef69f22c4680c2e78521cc53f1794f271537c6ee1c5887961079103305f3</originalsourceid><addsrcrecordid>eNptkU9rFDEYxoMottQevIsEvOhhNX8mycxF2K61LlTswZ5DmnnTDc4mY5Kp9Bv4sc12touCl-R9yI_nfcKD0EtK3lMqug-EEEFE0zZP0DFjnVx0XIqnj3ND-BE6zdnfVEpxJlr5HB1xxjgjgh-j38s-xzQWfwf4IpkwDdHeF8Am9PhrDLNYjhtIkH3G64zPnQP7wPuArwcLyTyoVRx8qchVlRBKxmexbPAvX4-d2W6IU6lYsHHriwkFXyXog89xiAFeoGfODBlO9_cJuv58_n31ZXH57WK9Wl4ubENks7DcAgcnO8eYbWRLLAPVCkatFdxR1TWOKSq4shKAWtG2qpOUqI4Szolw_AR9nH3H6WYLva1Rkxn0mPzWpHsdjdf_vgS_0bfxTivStUzJavB2b5Dizwly0VufLQyDCRCnrBmvcWoO1lb03YzaFHNO4A5rKNG78vShvMq-_jvXgXysqgJvZuCHSbeQDsB6_Wm20GO_-96r_1L7LX8Aa9GrjQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2385279428</pqid></control><display><type>article</type><title>Adsorptive Granulocyte and Monocyte Apheresis Is Effective in Ulcerative Colitis Patients Both with and without Concomitant Prednisolone</title><source>Karger Open Access</source><source>TestCollectionTL3OpenAccess</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Matsuda, Keiji ; Ohno, Kohei ; Okada, Yuka ; Yagi, Takahiro ; Tsukamoto, Mitsuo ; Fukushima, Yoshihisa ; Horiuchi, Atsushi ; Shimada, Ryu ; Ozawa, Tsuyoshi ; Hayama, Tamuro ; Tsuchiya, Takeshi ; Tamura, Junko ; Iinuma, Hisae ; Nozawa, Keijiro ; Aoyagi, Hitoshi ; Isono, Akari ; Abe, Koichiro ; Kodashima, Shinya ; Yamamoto, Takatsugu ; Kawasaki, Yoshitaka ; Tamura, Yoshifuru ; Sasajima, Yuko ; Kondo, Fukuo ; Hashiguchi, Yojiro</creator><creatorcontrib>Matsuda, Keiji ; Ohno, Kohei ; Okada, Yuka ; Yagi, Takahiro ; Tsukamoto, Mitsuo ; Fukushima, Yoshihisa ; Horiuchi, Atsushi ; Shimada, Ryu ; Ozawa, Tsuyoshi ; Hayama, Tamuro ; Tsuchiya, Takeshi ; Tamura, Junko ; Iinuma, Hisae ; Nozawa, Keijiro ; Aoyagi, Hitoshi ; Isono, Akari ; Abe, Koichiro ; Kodashima, Shinya ; Yamamoto, Takatsugu ; Kawasaki, Yoshitaka ; Tamura, Yoshifuru ; Sasajima, Yuko ; Kondo, Fukuo ; Hashiguchi, Yojiro</creatorcontrib><description>Background: The number of ulcerative colitis (UC) patients is increasing in Japan and other countries. Selective depletion of myeloid lineage leucocytes by adsorptive granulocyte and monocyte apheresis (GMA) with an Adacolumn (JIMRO, Takasaki, Japan) was introduced as a nonpharmacologic treatment strategy in UC patients in 2000. GMA has been reported to be effective in clinical trials; however, the effect of concomitant prednisolone (PSL) on GMA needs to be clarified. Methods: Thirty-nine patients with active UC were treated with GMA at our institute between June 2009 and September 2018. All patients received GMA therapy once or twice a week with the Adacolumn. Conventional medication was to be continued during the whole GMA treatment course. The clinical response was retrospectively evaluated. Results: According to the partial Mayo score, remission was 33.3%, significant efficacy 25.6%, effective 25.6%, and no response 15.4%. The average partial Mayo score was 6.2 ± 1.4 at entry and significantly declined to 1.8 ± 1.8 after GMA sessions (p &lt; 0.0001). The average number of bowel movements was 9.5 ± 5.6 at entry and significantly declined to 3.0 ± 2.8 after GMA sessions (p &lt; 0.0001). In a comparison between the group treated with concomitant PSL and the group without PSL, the change in partial Mayo score or the number of bowel movements from entry to after GMA sessions was not significantly different. Among 24 patients treated by GMA with concomitant PSL, 75% (18/24) became steroid free. Conclusions: The effect of GMA with concomitant PSL and that of GMA without PSL were not different, and GMA was effective irrespective of PSL administration. The present study showed that GMA had efficacy and led many UC patients treated by PSL to be steroid free with no safety concern in the real world, although there is the possibility of recruitment bias due to the retrospective nature of the study.</description><identifier>ISSN: 2296-9403</identifier><identifier>EISSN: 2296-9365</identifier><identifier>DOI: 10.1159/000505484</identifier><identifier>PMID: 32232053</identifier><language>eng</language><publisher>Basel, Switzerland: S. Karger AG</publisher><subject>Research Article</subject><ispartof>Inflammatory intestinal diseases, 2020-02, Vol.5 (1), p.36-41</ispartof><rights>2020 The Author(s) Published by S. Karger AG, Basel</rights><rights>Copyright © 2020 by S. Karger AG, Basel.</rights><rights>Copyright © 2020 by S. Karger AG, Basel 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4064-c3ce3ef69f22c4680c2e78521cc53f1794f271537c6ee1c5887961079103305f3</citedby><cites>FETCH-LOGICAL-c4064-c3ce3ef69f22c4680c2e78521cc53f1794f271537c6ee1c5887961079103305f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098276/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098276/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,860,881,27615,27904,27905,53771,53773</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32232053$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Matsuda, Keiji</creatorcontrib><creatorcontrib>Ohno, Kohei</creatorcontrib><creatorcontrib>Okada, Yuka</creatorcontrib><creatorcontrib>Yagi, Takahiro</creatorcontrib><creatorcontrib>Tsukamoto, Mitsuo</creatorcontrib><creatorcontrib>Fukushima, Yoshihisa</creatorcontrib><creatorcontrib>Horiuchi, Atsushi</creatorcontrib><creatorcontrib>Shimada, Ryu</creatorcontrib><creatorcontrib>Ozawa, Tsuyoshi</creatorcontrib><creatorcontrib>Hayama, Tamuro</creatorcontrib><creatorcontrib>Tsuchiya, Takeshi</creatorcontrib><creatorcontrib>Tamura, Junko</creatorcontrib><creatorcontrib>Iinuma, Hisae</creatorcontrib><creatorcontrib>Nozawa, Keijiro</creatorcontrib><creatorcontrib>Aoyagi, Hitoshi</creatorcontrib><creatorcontrib>Isono, Akari</creatorcontrib><creatorcontrib>Abe, Koichiro</creatorcontrib><creatorcontrib>Kodashima, Shinya</creatorcontrib><creatorcontrib>Yamamoto, Takatsugu</creatorcontrib><creatorcontrib>Kawasaki, Yoshitaka</creatorcontrib><creatorcontrib>Tamura, Yoshifuru</creatorcontrib><creatorcontrib>Sasajima, Yuko</creatorcontrib><creatorcontrib>Kondo, Fukuo</creatorcontrib><creatorcontrib>Hashiguchi, Yojiro</creatorcontrib><title>Adsorptive Granulocyte and Monocyte Apheresis Is Effective in Ulcerative Colitis Patients Both with and without Concomitant Prednisolone</title><title>Inflammatory intestinal diseases</title><addtitle>Inflamm Intest Dis</addtitle><description>Background: The number of ulcerative colitis (UC) patients is increasing in Japan and other countries. Selective depletion of myeloid lineage leucocytes by adsorptive granulocyte and monocyte apheresis (GMA) with an Adacolumn (JIMRO, Takasaki, Japan) was introduced as a nonpharmacologic treatment strategy in UC patients in 2000. GMA has been reported to be effective in clinical trials; however, the effect of concomitant prednisolone (PSL) on GMA needs to be clarified. Methods: Thirty-nine patients with active UC were treated with GMA at our institute between June 2009 and September 2018. All patients received GMA therapy once or twice a week with the Adacolumn. Conventional medication was to be continued during the whole GMA treatment course. The clinical response was retrospectively evaluated. Results: According to the partial Mayo score, remission was 33.3%, significant efficacy 25.6%, effective 25.6%, and no response 15.4%. The average partial Mayo score was 6.2 ± 1.4 at entry and significantly declined to 1.8 ± 1.8 after GMA sessions (p &lt; 0.0001). The average number of bowel movements was 9.5 ± 5.6 at entry and significantly declined to 3.0 ± 2.8 after GMA sessions (p &lt; 0.0001). In a comparison between the group treated with concomitant PSL and the group without PSL, the change in partial Mayo score or the number of bowel movements from entry to after GMA sessions was not significantly different. Among 24 patients treated by GMA with concomitant PSL, 75% (18/24) became steroid free. Conclusions: The effect of GMA with concomitant PSL and that of GMA without PSL were not different, and GMA was effective irrespective of PSL administration. The present study showed that GMA had efficacy and led many UC patients treated by PSL to be steroid free with no safety concern in the real world, although there is the possibility of recruitment bias due to the retrospective nature of the study.</description><subject>Research Article</subject><issn>2296-9403</issn><issn>2296-9365</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>M--</sourceid><recordid>eNptkU9rFDEYxoMottQevIsEvOhhNX8mycxF2K61LlTswZ5DmnnTDc4mY5Kp9Bv4sc12touCl-R9yI_nfcKD0EtK3lMqug-EEEFE0zZP0DFjnVx0XIqnj3ND-BE6zdnfVEpxJlr5HB1xxjgjgh-j38s-xzQWfwf4IpkwDdHeF8Am9PhrDLNYjhtIkH3G64zPnQP7wPuArwcLyTyoVRx8qchVlRBKxmexbPAvX4-d2W6IU6lYsHHriwkFXyXog89xiAFeoGfODBlO9_cJuv58_n31ZXH57WK9Wl4ubENks7DcAgcnO8eYbWRLLAPVCkatFdxR1TWOKSq4shKAWtG2qpOUqI4Szolw_AR9nH3H6WYLva1Rkxn0mPzWpHsdjdf_vgS_0bfxTivStUzJavB2b5Dizwly0VufLQyDCRCnrBmvcWoO1lb03YzaFHNO4A5rKNG78vShvMq-_jvXgXysqgJvZuCHSbeQDsB6_Wm20GO_-96r_1L7LX8Aa9GrjQ</recordid><startdate>20200201</startdate><enddate>20200201</enddate><creator>Matsuda, Keiji</creator><creator>Ohno, Kohei</creator><creator>Okada, Yuka</creator><creator>Yagi, Takahiro</creator><creator>Tsukamoto, Mitsuo</creator><creator>Fukushima, Yoshihisa</creator><creator>Horiuchi, Atsushi</creator><creator>Shimada, Ryu</creator><creator>Ozawa, Tsuyoshi</creator><creator>Hayama, Tamuro</creator><creator>Tsuchiya, Takeshi</creator><creator>Tamura, Junko</creator><creator>Iinuma, Hisae</creator><creator>Nozawa, Keijiro</creator><creator>Aoyagi, Hitoshi</creator><creator>Isono, Akari</creator><creator>Abe, Koichiro</creator><creator>Kodashima, Shinya</creator><creator>Yamamoto, Takatsugu</creator><creator>Kawasaki, Yoshitaka</creator><creator>Tamura, Yoshifuru</creator><creator>Sasajima, Yuko</creator><creator>Kondo, Fukuo</creator><creator>Hashiguchi, Yojiro</creator><general>S. Karger AG</general><scope>M--</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20200201</creationdate><title>Adsorptive Granulocyte and Monocyte Apheresis Is Effective in Ulcerative Colitis Patients Both with and without Concomitant Prednisolone</title><author>Matsuda, Keiji ; Ohno, Kohei ; Okada, Yuka ; Yagi, Takahiro ; Tsukamoto, Mitsuo ; Fukushima, Yoshihisa ; Horiuchi, Atsushi ; Shimada, Ryu ; Ozawa, Tsuyoshi ; Hayama, Tamuro ; Tsuchiya, Takeshi ; Tamura, Junko ; Iinuma, Hisae ; Nozawa, Keijiro ; Aoyagi, Hitoshi ; Isono, Akari ; Abe, Koichiro ; Kodashima, Shinya ; Yamamoto, Takatsugu ; Kawasaki, Yoshitaka ; Tamura, Yoshifuru ; Sasajima, Yuko ; Kondo, Fukuo ; Hashiguchi, Yojiro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4064-c3ce3ef69f22c4680c2e78521cc53f1794f271537c6ee1c5887961079103305f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Research Article</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Matsuda, Keiji</creatorcontrib><creatorcontrib>Ohno, Kohei</creatorcontrib><creatorcontrib>Okada, Yuka</creatorcontrib><creatorcontrib>Yagi, Takahiro</creatorcontrib><creatorcontrib>Tsukamoto, Mitsuo</creatorcontrib><creatorcontrib>Fukushima, Yoshihisa</creatorcontrib><creatorcontrib>Horiuchi, Atsushi</creatorcontrib><creatorcontrib>Shimada, Ryu</creatorcontrib><creatorcontrib>Ozawa, Tsuyoshi</creatorcontrib><creatorcontrib>Hayama, Tamuro</creatorcontrib><creatorcontrib>Tsuchiya, Takeshi</creatorcontrib><creatorcontrib>Tamura, Junko</creatorcontrib><creatorcontrib>Iinuma, Hisae</creatorcontrib><creatorcontrib>Nozawa, Keijiro</creatorcontrib><creatorcontrib>Aoyagi, Hitoshi</creatorcontrib><creatorcontrib>Isono, Akari</creatorcontrib><creatorcontrib>Abe, Koichiro</creatorcontrib><creatorcontrib>Kodashima, Shinya</creatorcontrib><creatorcontrib>Yamamoto, Takatsugu</creatorcontrib><creatorcontrib>Kawasaki, Yoshitaka</creatorcontrib><creatorcontrib>Tamura, Yoshifuru</creatorcontrib><creatorcontrib>Sasajima, Yuko</creatorcontrib><creatorcontrib>Kondo, Fukuo</creatorcontrib><creatorcontrib>Hashiguchi, Yojiro</creatorcontrib><collection>Karger Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Inflammatory intestinal diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Matsuda, Keiji</au><au>Ohno, Kohei</au><au>Okada, Yuka</au><au>Yagi, Takahiro</au><au>Tsukamoto, Mitsuo</au><au>Fukushima, Yoshihisa</au><au>Horiuchi, Atsushi</au><au>Shimada, Ryu</au><au>Ozawa, Tsuyoshi</au><au>Hayama, Tamuro</au><au>Tsuchiya, Takeshi</au><au>Tamura, Junko</au><au>Iinuma, Hisae</au><au>Nozawa, Keijiro</au><au>Aoyagi, Hitoshi</au><au>Isono, Akari</au><au>Abe, Koichiro</au><au>Kodashima, Shinya</au><au>Yamamoto, Takatsugu</au><au>Kawasaki, Yoshitaka</au><au>Tamura, Yoshifuru</au><au>Sasajima, Yuko</au><au>Kondo, Fukuo</au><au>Hashiguchi, Yojiro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Adsorptive Granulocyte and Monocyte Apheresis Is Effective in Ulcerative Colitis Patients Both with and without Concomitant Prednisolone</atitle><jtitle>Inflammatory intestinal diseases</jtitle><addtitle>Inflamm Intest Dis</addtitle><date>2020-02-01</date><risdate>2020</risdate><volume>5</volume><issue>1</issue><spage>36</spage><epage>41</epage><pages>36-41</pages><issn>2296-9403</issn><eissn>2296-9365</eissn><abstract>Background: The number of ulcerative colitis (UC) patients is increasing in Japan and other countries. Selective depletion of myeloid lineage leucocytes by adsorptive granulocyte and monocyte apheresis (GMA) with an Adacolumn (JIMRO, Takasaki, Japan) was introduced as a nonpharmacologic treatment strategy in UC patients in 2000. GMA has been reported to be effective in clinical trials; however, the effect of concomitant prednisolone (PSL) on GMA needs to be clarified. Methods: Thirty-nine patients with active UC were treated with GMA at our institute between June 2009 and September 2018. All patients received GMA therapy once or twice a week with the Adacolumn. Conventional medication was to be continued during the whole GMA treatment course. The clinical response was retrospectively evaluated. Results: According to the partial Mayo score, remission was 33.3%, significant efficacy 25.6%, effective 25.6%, and no response 15.4%. The average partial Mayo score was 6.2 ± 1.4 at entry and significantly declined to 1.8 ± 1.8 after GMA sessions (p &lt; 0.0001). The average number of bowel movements was 9.5 ± 5.6 at entry and significantly declined to 3.0 ± 2.8 after GMA sessions (p &lt; 0.0001). In a comparison between the group treated with concomitant PSL and the group without PSL, the change in partial Mayo score or the number of bowel movements from entry to after GMA sessions was not significantly different. Among 24 patients treated by GMA with concomitant PSL, 75% (18/24) became steroid free. Conclusions: The effect of GMA with concomitant PSL and that of GMA without PSL were not different, and GMA was effective irrespective of PSL administration. The present study showed that GMA had efficacy and led many UC patients treated by PSL to be steroid free with no safety concern in the real world, although there is the possibility of recruitment bias due to the retrospective nature of the study.</abstract><cop>Basel, Switzerland</cop><pub>S. Karger AG</pub><pmid>32232053</pmid><doi>10.1159/000505484</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2296-9403
ispartof Inflammatory intestinal diseases, 2020-02, Vol.5 (1), p.36-41
issn 2296-9403
2296-9365
language eng
recordid cdi_crossref_primary_10_1159_000505484
source Karger Open Access; TestCollectionTL3OpenAccess; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Research Article
title Adsorptive Granulocyte and Monocyte Apheresis Is Effective in Ulcerative Colitis Patients Both with and without Concomitant Prednisolone
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T10%3A05%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Adsorptive%20Granulocyte%20and%20Monocyte%20Apheresis%20Is%20Effective%20in%20Ulcerative%20Colitis%20Patients%20Both%20with%20and%20without%20Concomitant%20Prednisolone&rft.jtitle=Inflammatory%20intestinal%20diseases&rft.au=Matsuda,%20Keiji&rft.date=2020-02-01&rft.volume=5&rft.issue=1&rft.spage=36&rft.epage=41&rft.pages=36-41&rft.issn=2296-9403&rft.eissn=2296-9365&rft_id=info:doi/10.1159/000505484&rft_dat=%3Cproquest_cross%3E2385279428%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2385279428&rft_id=info:pmid/32232053&rfr_iscdi=true